Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PURINETHOL TEVA CANADA LIMITED Resolved 50MG Updated Report 2025-12-06 231946
SEROQUEL XR CHEPLAPHARM ARZNEIMITTEL GMBH Resolved 200MG Updated Report 2025-12-06 263832
DEPO-MEDROL PFIZER CANADA ULC Actual shortage 80MG Updated Report 2025-12-06 271103
MAGNESIUM SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 500MG Updated Report 2025-12-06 271349
MYLAN-PROPAFENONE MYLAN PHARMACEUTICALS ULC Actual shortage 300MG Updated Report 2025-12-06 271408
IMITREX GLAXOSMITHKLINE INC Actual shortage 20MG Updated Report 2025-12-06 271901
MYXREDLIN BAXTER CORPORATION Actual shortage 1UNIT Updated Report 2025-12-06 272638
ADMELOG SOLOSTAR SANOFI-AVENTIS CANADA INC Resolved 100UNIT Updated Report 2025-12-06 272482
APO-ESOMEPRAZOLE APOTEX INC Actual shortage 20MG Updated Report 2025-12-05 271937
ZAMINE 28 APOTEX INC Resolved 0.03MG 3MG Updated Report 2025-12-05 270732

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 500MG Updated Report 2025-12-06 273434
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 750MG Updated Report 2025-12-06 273437
NAT-OMEPRAZOLE DR NATCO PHARMA (CANADA) INC Discontinued 20MG Updated Report 2025-12-06 273440
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 25MG Updated Report 2025-12-06 273482
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 100MG Updated Report 2025-12-06 273489
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 200MG Updated Report 2025-12-06 273496
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 300MG Updated Report 2025-12-06 273501
NAT-DONEPEZIL NATCO PHARMA (CANADA) INC Discontinued 5MG Updated Report 2025-12-06 273383
NAT-DONEPEZIL NATCO PHARMA (CANADA) INC Discontinued 10MG Updated Report 2025-12-06 273387
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 250MG Updated Report 2025-12-06 273390